3 Results for "

ADME prediction

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "ADME prediction" in MCE Product Catalog:

Cat. No.: HY-147027
CAS No.: 684234-55-7
Purity:  99.48%
PARP-1-IN-2 (compound 11g) is a potent PARP1 inhibitor, with an IC50 of 149 nM, and ADME prediction indicates it has high blood-brain barrier permeability. PARP1-IN-2 shows significantly potent anti-proliferative activity against Human lung adenocarcinoma epithelial cell line A549. PARP1-IN-2 can induce A549 cells apoptosis .
loading...
    loading...
Cat. No.: HY-163415
CAS No.: 906728-07-2
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

MAO-IN-5 (Compound ZINC000016952895) is a monoamine oxidase (MAO) inhibitor. According to the prediction of Swiss ADME, MAO-IN-5 can inhibit the CYP enzyme family, has blood-brain barrier (BBB) permeability, and has a high gastrointestinal absorption rate. MAO-IN-5 can be used in the study of neurological diseases .
loading...
    loading...
Cat. No.: HY-175245
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

hCA-IN-1 (Compound 5u) is an hCA inhibitor with Ki values of 159.2, 4.8, 15.5, and 2 nM against hCA I, hCA II, hCA IX, and hCA XII, respectively. hCA-IN-1 exhibits broad-spectrum anticancer activity against melanoma, breast, and colon cancer cells. ADME predictions indicate that hCA-IN-1 has good solubility and oral bioavailability. hCA-IN-1 can be used in tumor research .
loading...
    loading...